Table 2.
Mesenteric Artery | Pulmonary Artery | |||||
Groups | ACh | SNP | PHE | ACh | SNP | PHE |
SAL | 7.26 ± 0.06 | 8.58 ± 0.07 | 6.88 ± 0.06 | 6.86 ± 0.07 | 8.02 ± 0.05 | 7.00 ± 0.09 |
TAU | 6.64 ± 0.14* | 8.67 ± 0.06 | 6.54 ± 0.09* | 6.66 ± 0.8 | 8.18 ± 0.08 | 6.57 ± 0.05* |
PLA2 | 6.42 ± 0.08* | 8.79 ± 0.04 | 6.74 ± 0.12 | 6.69 ± 0.10 | 8.02 ± 0.09 | 6.92 ± 0.07 |
Potency (pEC50) of acetylcholine (ACh), sodium nitroprusside (SNP) and phenylephrine (PHE) obtained from concentration-response curves in mesenteric and pulmonary rings from saline (SAL); taurocholate (TAU) and phospholipase A2 (PLA2) groups. Potency is represented as -log of the molar concentration to produce 50% of the maximal response. Data are mean ± SEM for 5–9 animals. * different from SAL (P < 0.05).